Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral misoprostol versus oxytocin for induction of labor in preterm premature rupture of membranes
IRCT20191104045333N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of misoprostol and oxytocin in Preterm prelabor rupture of membranes (PPROM) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Induction of labor. Started Feb 2020; status: completed.
02
Drugs
misoprostoloxytocin
03
Conditions
Preterm prelabor rupture of membranes (PPROM)
Beyond the preview
Go deeper on IRCT20191104045333N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045333N1.